Companion Animal Vaccines Market Size, Share & Industry Analysis, By Product (Inactivated, Live Attenuated, Recombinant, and Others), By Animal Type (Feline, Canine, Avian, and Others), By Route of Administration (Oral, Parenteral, and Others), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, and Others), and Regional Forecast, 2025-2032

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2024

Estimated Year

2025

Forecast Period

2025-2032

Historical Period

2019-2023

Growth Rate

CAGR of 6.3% from 2025 to 2032

Unit

Value (USD Billion)

Segmentation

By Product

• Inactivated
• Live Attenuated
• Recombinant
• Others

By Animal Type

• Feline
• Canine
• Avian
• Others

By Route of Administration

• Oral
• Parenteral
• Others

By Distribution Channel

• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies & Drug Stores
• Others

By Region

• North America (By Product, Animal Type, Route of Administration, Distribution Channel, Country/ Sub-Region)
  • U.S.
  • Canada
• Europe (By Product, Animal Type, Route of Administration, Distribution Channel, Country/ Sub-Region)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Product, Animal Type, Route of Administration, Distribution Channel, Country/ Sub-Region)
  • Japan
  • China
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Product, Animal Type, Route of Administration, Distribution Channel, Country/ Sub-Region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Product, Animal Type, Route of Administration, Distribution Channel, Country/ Sub-Region)
  • GCC
  • South Africa
• Rest of the Middle East & Africa